The prolyl oligopeptidase inhibitor KYP‑2047 is not readily bioavailable to bloodstream form trypanosomes and human myelocytic leukemia cells. Journal of Pharmaceutical Negative Results. 2015;6(1):7-10. Accessed May 14, 2026. https://mail.pnrjournal.com/index.php/home/article/view/84